Proof of concept.
Infinity BiologiX (IBX), a global leader in biobanking, bioprocessing, and analytics with over 50 years of biomaterial expertise, recently spun out from Rutgers University, requiring a new facility to enhance and accelerate its mission. The world’s largest university-based biorepository, IBX seeks to understand the genetic causes of common, complex diseases and discover diagnoses, treatments and, eventually, cures. Currently housed in a 30,000-square-foot temporary space at MSC, IBX will expand into a state-of-the-art, 200,000-square-foot space, consolidating its growth at MSC. By utilizing MSC’s technologically advanced infrastructure and the highest quality biomaterials, IBX scientists will be best positioned to continue converting precious biosamples into renewable resources, thereby extending research capabilities.
“As a fully functional biorepository, our capabilities span the entire life cycle of a sample. We are staffed 24/7/365 to ensure timely processing of samples. MSC’s in-place infrastructure checked all the boxes in satisfying our speed to market lab needs,” said Jitesh Patel, Senior Director of Infrastructure and Logistics at IBX.